Quarterly report pursuant to Section 13 or 15(d)

Debt (Detail Textuals)

v3.20.2
Debt (Detail Textuals) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Nov. 01, 2018
Nov. 01, 2018
Oct. 05, 2018
Apr. 24, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Aug. 04, 2020
Dec. 31, 2018
Debt Instrument [Line Items]                      
Derivative liability         $ 465,287 $ 11,178,925 $ 465,287 $ 11,178,925 $ 501,400   $ 15,958,366
Convertible multi-draw credit agreement issuance costs             $ 63,007        
Unamortized debt discount period             2 years 3 months 7 days        
Fair value of derivative liabilities in excess of proceeds         0 $ 0 $ 0 $ 322,644      
Carrying value of the equity component         790,691   790,691        
Subsequent Event                      
Debt Instrument [Line Items]                      
Warrant exercise price                   $ 0.075  
Paycheck Protection Program                      
Debt Instrument [Line Items]                      
Maturity date       Apr. 24, 2022              
Debt Instrument, Face Amount       $ 116,700              
Interest rate       1.00%              
Payroll Costs Exclude Compensation       $ 100,000              
Percentage of forgiveness amount for nonpayroll costs       25.00%              
Amount of salaries       $ 100,000              
Percentage of reduction in annual salary       25.00%              
Multi-Draw Credit Agreement                      
Debt Instrument [Line Items]                      
Warrant exercise price $ 0.50 $ 0.50       $ 0.50   $ 0.50      
Warrants and Rights Outstanding           $ 2,000,000   $ 2,000,000      
Proceeds from related party debt $ 2,000,000                    
Number of warrant issued 2,500,000 2,500,000       5,000,000   5,000,000      
Allocation of debt on the basis of relative fair value $ 1,684,920 $ 1,684,920       $ 3,283,890   $ 3,283,890      
Allocation of warrant on the basis of relative fair value 315,080 315,080       716,110   716,110      
Beneficial conversion feature   90,080           1,584,850      
Derivative liability $ 204,102 $ 204,102       516,058   516,058      
Proceeds from warrant exercises                 3,985,500    
Loss on extinguishment of debt                 725,425    
Fair value of derivative liabilities in excess of proceeds               322,644      
Debt Instrument, Face Amount           4,000,000   4,000,000      
Emerald Financing                      
Debt Instrument [Line Items]                      
Derivative liability         352,732 $ 10,363,484 352,732 $ 10,363,484 $ 276,024   $ 15,251,413
Emerald Financing | Multi-Draw Credit Agreement                      
Debt Instrument [Line Items]                      
Maximum amount that can be borrowed over the life of the credit facility     $ 20,000,000                
Interest rate percentage     7.00%                
Maturity date     Oct. 05, 2022                
Unused portion of the credit facility             $ 13,550,000        
Warrant coverage on the debt facility     50.00%                
Warrant exercise price     $ 0.50                
Warrant exercise price     0.35                
Emerald Health Sciences Inc [Member] | Multi-Draw Credit Agreement                      
Debt Instrument [Line Items]                      
Conversion price     $ 0.25                
Amount of capital raise     $ 5,000,000                
Emerald Health Sciences Inc [Member] | Independent contractor agreement                      
Debt Instrument [Line Items]                      
Credit Facility Effected Fourth Advances         150,000            
Credit Facility Effected Fifth Advances         $ 300,000